Phibro Animal Health (PAHC) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Phibro Animal Health (PAHC) PT Raised to $35 at Guggenheim on 'Beat and Raise' Q1
November 12, 2014 10:27 AM ESTGuggenheim analyst Louise Chen reiterated a Buy rating and boosted her price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $35.00 (from $24.00) following 'beat and raise' Q1 results.
Chen said the Q1 positives that support their Buy thesis are: 1) Good volume... More
